Author

B. Warth

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 3 Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Approach:experimental assay· 4 Assay:metabolomics· 3 Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

C. Johnson· 2 shared D. Braun· 2 shared G. Siuzdak· 2 shared A. Granados· 1 shared A. Mazurek· 1 shared A. Palermo· 1 shared A. Rompel· 1 shared C. N. Ezekiel· 1 shared

Activity by Year

2017-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 12 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

C. Johnson

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Insights into the early-life chemical exposome of Nigerian infants and potential correlations with the developing gut microbiome

I. Oesterle, K. I. Ayeni, C. N. Ezekiel, D. Berry, A. Rompel, B. Warth

This study identifies and correlates xenobiotics in breast milk and infant stool from Nigerian mother-infant pairs, showing links between chemical exposure and gut microbiome composition.

bioRxiv · Nov 8, 2023Pharmacology & Toxicology

A broad, exposome-type evaluation of xenobiotic phase II biotransformation in human biofluids by LC-MS/MS

Y. Fareed, D. Braun, M. Flasch, D. Globisch, B. Warth

The paper evaluates phase II biotransformation enzymes for xenobiotic deconjugation in human biofluids using LC-MS/MS, finding H. pomatia is most efficient overall but recombinant BGS is better for breast milk due to lower contamination.

bioRxiv · Jul 15, 2022Pharmacology & Toxicology

Longitudinal assessment of mycotoxin co-exposures in exclusively breastfed infants

D. Braun, E. Schernhammer, D. Marko, B. Warth

This paper assesses mycotoxin exposure in breast milk over 211 days in a single infant, finding low concentrations of several mycotoxins with potential for chronic low-dose exposure.

bioRxiv · Mar 27, 2020Pharmacology & Toxicology

Palbociclib and fulvestrant act in synergy to modulate central carbon metabolism in breast cancer cells

B. Warth, A. Palermo, N. Rattray, N. Lee, Z. Zhu, L. Hoang, A. Mazurek, S. Dann, T. VanArsdale, V. Fantin, D. Shields, G. Siuzdak, C. Johnson

This study investigates how palbociclib and fulvestrant affect metabolic pathways in breast cancer cells, finding synergistic effects when combined.

bioRxiv · Jun 16, 2018Biochemistry

Metabolomics reveals that dietary xenoestrogens alter cellular metabolism induced by palbociclib/letrozole combination cancer therapy

B. Warth, P. Raffeiner, A. Granados, T. Huan, M. Fang, E. M. Forsberg, H. P. Benton, L. Goetz, C. Johnson, G. Siuzdak

The paper uses metabolomics to show that dietary xenoestrogens alter cellular metabolism in response to palbociclib/letrozole cancer therapy in MCF-7 cells.

bioRxiv · Oct 31, 2017Cancer Biology